Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial

NCT05159960 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT05159960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05159960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial
Lead sponsor
Vastra Gotaland Region
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 10, 2022
Completion date
December 31, 2027
Enrollment
400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, open-angle, ocular hypertension, pseudoexfoliation glaucoma